RecruitingNCT05984680
COPD Care Pathway Among Patients With Cancer
User-Centered Design of a COPD Care Pathway for Patients With Cancer
Sponsor
Wake Forest University Health Sciences
Enrollment
101 participants
Start Date
Feb 27, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This study gathers information for the development of a COPD care pathway for patients with cancer that reduces the treatment burden of patients, implements critical components of COPD care, and overcomes common barriers to COPD care in the community oncology clinic.
Eligibility
Min Age: 18 Years
Inclusion Criteria7
- The participant has personal experience with medical management of COPD, defined as meeting at least one of the following criteria:
- patient with clinical documentation of COPD (either as a confirmed or suspected diagnosis) and has received at least one dose of an immune checkpoint inhibitor for cancer or
- provider who currently works at least part-time in a medical oncology clinic or
- provider who works at least part-time to care for patients with known or suspected COPD.
- A suspected diagnosis of COPD can be based on finding(s) by history, exam, or radiography (e.g., CT changes such as emphysema, bronchial wall thickening, or mucus plugging). A provider is defined as a physician, advanced practice provider, nurse, or respiratory therapist. Study team members are permitted to participate in the study if they meet eligibility criteria.
- Ability to understand and agree to participate on the study as described by the study information sheet.
- Capability of speaking or reading English.
Interventions
OTHERObservational Phase 1
Noninterventional study
OTHERObservational Phase 2, Group I
Noninterventional study
OTHERObservational Phase 2, Group II
Noninterventional study
OTHERObservational Phase 3
Noninterventional study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05984680
Related Trials
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
NCT046786483 locations
Virtual Agent Feasibility in Oncology Patients (NTT Data)
NCT066820131 location
Empathic Communication Skills (ECS) Training
NCT0545684112 locations
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Study of Novel Treatment Combinations in Patients With Lung Cancer
NCT05633667100 locations